Showing results (141-150 of 4,547) with videos related to

Sort By:
Pageof 455
Drug Development and Industrial Pharmacy|October 20, 2004
Influence of the size of micronized active pharmaceutical ingredient on the aerodynamic particle size and stability of a metered dose inhalerJulianne Berry, Lukeysha C Kline, Jill K Sherwood, et al.
Drug Development and Industrial Pharmacy|November 24, 2004
Development of the bioadhesive tetracaine gels for enhanced local anesthetic effectsSang-Chul Shin, Cheong-Weon Cho, Jun-Shik Choi
Drug Development and Industrial Pharmacy|November 24, 2004
Comparison studies on the percolation thresholds of binary mixture tablets containing excipients of plastic/brittle and plastic/plastic deformation propertiesMohd C I Amin, John T Fell
Drug Development and Industrial Pharmacy|November 24, 2004
Studies on acyclovir-dextran conjugate: synthesis and pharmacokineticsJiasheng Tu, Sha Zhong, Pengmei Li
Drug Development and Industrial Pharmacy|November 24, 2004
Solution stability of factor Xa inhibitors as a function of pHPei Yang, Fraser Macdonald
Drug Development and Industrial Pharmacy|November 24, 2004
Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulationNoha Adel Nafee, Fatma Ahmed Ismail, Nabila Ahmed Boraie, et al.
Drug Development and Industrial Pharmacy|November 24, 2004
Mucoadhesive delivery systems. II. Formulation and in-vitro/in-vivo evaluation of buccal mucoadhesive tablets containing water-soluble drugsNoha Adel Nafee, Fatma Ahmed Ismail, Nabila Ahmed Boraie, et al.
Drug Development and Industrial Pharmacy|December 18, 2003
Conditioning following powder micronization: influence on particle growth of salbutamol sulfateKatharina Brodka-Pfeiffer, Heribert Häusler, Peter Grass, et al.
Drug Development and Industrial Pharmacy|December 18, 2003
Talc functionality as lubricant: texture, mean diameter, and specific surface area influenceJ Ribet, K Poret, D Arseguel, et al.
Drug Development and Industrial Pharmacy|March 6, 2004
Powder-in-bottle formulation of SU011248. Enabling rapid progression into human clinical trialsAnand Sistla, Alan Sunga, Kenneth Phung, et al.
Pageof 455